Advisory Alpha’s Bio-Techne TECH Stock Holding History

Advisory Alpha’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$321K	Buy	6,142 +1,577	+35%	+$94.7K	0.01%	439
2025 Q4	$268K	Buy	4,565 +441	+11%	+$26.8K	0.01%	443
2025 Q3	$256K	Buy	+4,124	New	+$221K	0.01%	448

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Advisory Alpha's TECH Position: Q1 2026 in Review

Advisory Alpha increased its Bio-Techne (TECH) stake by 35% in Q1 2026, buying an estimated $94.7K and bringing the position to 6,142 shares worth $321K. The position accounts for 0.01% of the portfolio, ranked #439.

Advisory Alpha first reported a position in TECH in Q3 2025 and has held it in 3 quarters since. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

Advisory Alpha held 6,142 shares of Bio-Techne worth $321K as of Q1 2026.
Advisory Alpha bought 1,577 Bio-Techne shares in Q1 2026, an estimated $94.7K.
Bio-Techne made up 0.01% of Advisory Alpha's portfolio in Q1 2026, its #439 holding.
Advisory Alpha first reported a position in Bio-Techne in Q3 2025 and has held it in 3 quarters since.
582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Advisory Alpha's 13F filing for Q1 2026, filed 14 May 2026.